NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 992.00
-15.00 (-1.49%)
At close: Jun 5, 2026
NGeneBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -7,000 | -5,542 | -12,976 | -12,769 | -9,785 | -8,431 |
Depreciation & Amortization | 1,752 | 2,227 | 2,932 | 1,344 | 1,274 | 1,030 |
Loss (Gain) From Sale of Assets | 1,639 | 1,936 | 14.8 | 20.85 | 0.99 | 11.15 |
Asset Writedown & Restructuring Costs | 2,026 | 2,012 | 34.04 | 97.62 | 34.1 | 24.56 |
Loss (Gain) From Sale of Investments | -8,141 | -8,158 | 855.76 | 526.16 | 144.52 | - |
Loss (Gain) on Equity Investments | - | - | - | - | - | -199.05 |
Stock-Based Compensation | -41.04 | 14.32 | 43.22 | 0.2 | 241.31 | 501.98 |
Provision & Write-off of Bad Debts | 292.03 | 265.27 | 24.1 | 172.03 | - | - |
Other Operating Activities | 3,856 | 1,050 | -3,100 | 1,600 | 2,445 | 563.07 |
Change in Accounts Receivable | 908.28 | -737.74 | 115.76 | 166.34 | 456.28 | -1,134 |
Change in Inventory | 53.98 | 394.24 | -98.3 | -116.18 | -1,893 | 21.03 |
Change in Accounts Payable | -69.65 | -629.84 | 202.39 | 93.57 | -103.67 | -218.25 |
Change in Unearned Revenue | 0.01 | 0.04 | -0 | -20.17 | 1.83 | -16.22 |
Change in Other Net Operating Assets | -467.33 | -1,313 | -479.22 | -282.74 | -636.23 | 323.61 |
Operating Cash Flow | -5,193 | -8,482 | -12,431 | -9,167 | -7,820 | -7,523 |
Capital Expenditures | -26,628 | -25,852 | -135.37 | -386.37 | -1,029 | -3,023 |
Sale of Property, Plant & Equipment | 48.08 | 132.7 | 449.48 | - | - | - |
Cash Acquisitions | -276.86 | -276.86 | -7,520 | - | - | 20.72 |
Sale (Purchase) of Intangibles | -160 | -78.97 | -103.45 | -441.76 | -196.22 | -349.22 |
Investment in Securities | 585.68 | 40.13 | 1,499 | 4,885 | 1,918 | -13,348 |
Other Investing Activities | -936.15 | -941.79 | -186.83 | 74.57 | -107.76 | -679.42 |
Investing Cash Flow | -36,041 | -26,927 | -5,997 | 4,131 | 585.23 | -17,378 |
Short-Term Debt Issued | - | 13,794 | 5,900 | - | - | 1,100 |
Long-Term Debt Issued | - | 24,885 | 5,510 | - | 19,866 | 500 |
Total Debt Issued | 50,104 | 38,679 | 11,410 | - | 19,866 | 1,600 |
Short-Term Debt Repaid | - | -14,787 | -3,300 | -500 | -3,600 | - |
Long-Term Debt Repaid | - | -1,360 | -19,172 | -327.9 | -1,116 | -162.54 |
Total Debt Repaid | -27,444 | -16,147 | -22,472 | -827.9 | -4,716 | -162.54 |
Net Debt Issued (Repaid) | 22,660 | 22,532 | -11,062 | -827.9 | 15,151 | 1,437 |
Issuance of Common Stock | 9,467 | 9,467 | 12,593 | 220.35 | 516.93 | 457.15 |
Other Financing Activities | 10,176 | 980.86 | 2,022 | - | 130 | - |
Financing Cash Flow | 42,302 | 32,980 | 3,553 | -607.55 | 15,797 | 1,895 |
Foreign Exchange Rate Adjustments | -62.82 | -50.59 | 30.41 | 20.72 | 38.95 | 0.11 |
Miscellaneous Cash Flow Adjustments | -7.88 | -7.88 | - | - | 0 | - |
Net Cash Flow | 998.03 | -2,488 | -14,844 | -5,623 | 8,601 | -23,006 |
Free Cash Flow | -31,821 | -34,334 | -12,566 | -9,553 | -8,849 | -10,546 |
Free Cash Flow Margin | -101.99% | -161.65% | -223.95% | -219.57% | -80.32% | -147.22% |
Free Cash Flow Per Share | -1323.49 | -1526.80 | -886.12 | -753.13 | -709.15 | -852.68 |
Cash Interest Paid | 760.86 | 460.45 | 366.99 | 81.53 | 146.88 | 141.93 |
Cash Income Tax Paid | - | -59.13 | -102.83 | 36.48 | 96.12 | 20.01 |
Levered Free Cash Flow | -33,120 | -34,252 | -13,556 | -10,880 | 5,799 | - |
Unlevered Free Cash Flow | -31,481 | -33,229 | -12,486 | -9,767 | 6,215 | - |
Change in Working Capital | 425.29 | -2,286 | -259.38 | -159.18 | -2,175 | -1,024 |